key: cord-0938914-moxq6wrq
authors: D, Vitalakumar; Sharma, Ankita; Kumar, Anoop; Flora, S. J. S.
title: Neurological Manifestations in COVID-19 Patients: A Meta-Analysis
date: 2021-07-14
journal: ACS Chem Neurosci
DOI: 10.1021/acschemneuro.1c00353
sha: 6f80231233c66a1dfaed9ce9ee6aee9bc5d5e9f8
doc_id: 938914
cord_uid: moxq6wrq

[Image: see text] Common symptoms such as dizziness, headache, olfactory dysfunction, nausea, vomiting, etc. in COVID-19 patients have indicated the involvement of the nervous system. However, the exact association of the nervous system with COVID-19 infection is still unclear. Thus, we have conducted a meta-analysis of clinical studies associated with neurological problems in COVID-19 patients. We have searched for electronic databases with MeSH terms, and the studies for analysis were selected based on inclusion and exclusion criteria and quality assessment. The Stats Direct (version 3) was used for the analysis. The pooled prevalence with 95% confidence interval of various neurological manifestations reported in the COVID-19 patients was found to be headache 14.6% (12.2–17.2), fatigue 33.6% (29.5–37.8), olfactory dysfunction 26.4% (21.8–31.3), gustatory dysfunction 27.2% (22.3–32.3), vomiting 6.7% (5.5–8.0), nausea 9.8% (8.1–11.7), dizziness 6.7% (4.7–9.1), myalgia 21.4% (18.8–24.1), seizure 4.05% (2.5–5.8), cerebrovascular diseases 9.9% (6.8–13.4), sleep disorders 14.9% (1.9–36.8), altered mental status 17.1% (12.3–22.5), neuralgia 2.4% (0.8–4.7), arthralgia 19.9% (15.3–25.0), encephalopathy 23.5% (14.3–34.1), encephalitis 0.6% (0.2–1.3), malaise 38.3% (24.7–52.9), confusion 14.2% (6.9–23.5), movement disorders 5.2% (1.7–10.4), and Guillain–Barre syndrome 6.9% (2.3–13.7). However, the heterogeneity among studies was found to be high. Various neurological manifestations related to the central nervous system (CNS) and peripheral nervous system (PNS) are associated with COVID-19 patients.

In December 2019, Wuhan, the capital city of Hubei province, started reporting to hospitals with severe pneumonia. On etiologic investigation of respiratory samples, on December 31, 2019, China reported the epidemic to the World Health Organization. The infection was named Coronavirus Disease-19 (COVID- 19) , and it was caused by the SARS CoV-2. 1 As of January 10, 2021, the COVID-19 pandemic had affected 222 countries across the globe with 87M positive cases and 1.9M deaths. 2 COVID-19 patients presented with a varied range of symptoms from asymptomatic to severe respiratory failure. The most common symptoms include fever, cough, fatigue, anorexia, headache, and myalgia. 3 In addition to respiratory illness, several cardiovascular and neurological manifestations were also found to be associated with COVID-19 infection. 4, 5 The COVID-19 related neurological manifestations are hypothesized to be caused by multiple factors such as damage to specific receptors, secondary hypoxia, cytokine-related injury, and retrograde travel along the olfactory nerve and bulb. 6 −10 Additionally, global inflammatory markers such as interleukin (IL)-6, IL-12, IL-15, and tumor necrosis factor α (TNF-α) can activate glial cells and produce inflammatory responses. 8 These systemic consequences along with lung alveolar damage cause severe hypoxia, which leads to 

A total of 75 454 articles were identified in the searched databases. After the removal of duplicates, 59 580 titles and abstracts were screened. From these, 59 133 articles were excluded and 447 full-text articles were screened for eligibility. After screening, 246 studies were included in the qualitative synthesis whereas 240 studies were included in the quantitative synthesis. The scheme of selection of studies for analysis is shown in Figure 1 .

The included studies were prospective and retrospective observational cohort studies, cross-sectional studies, and case-control studies. The demographic characteristics including study design, sample size, study setting, age, and sex ratio in patients of included studies are shown in Table 1 .

3.2. Quality Assessment. All cohort, cross-sectional and, case-control studies with one protocol assessed for methodological quality on the NOS were found to be good, fair, and poor quality, based on the scores of the study in selection, −52.9 ), respectively. The dizziness was found to be significant with a pooled proportion of 6.7% (4.7−9.1). Nausea and vomiting were also found prominent in COVID-19 patients with pooled proportions of 9.8% (8.1−11.7) and 6.7% Apart from these, some manifestations that are reported rarely are listed in Table 2 . The prevalence of neurological manifestations in COVID-19 patients is shown in Table 3 . The meta-analysis, summary estimate of pooled prevalence, and heterogeneity of the same are shown in Table 4 .

3.5. Heterogeneity. The heterogeneity among all included studies was found to be high for all the neurological manifestations with an I 2 value ranging from 90.3% to 99.5%.

3.6. Publication Bias. The funnel plot has indicated the involvement of publication bias in the majority of studies related to neurological manifestations. The publication bias was further confirmed by Eggers's test (p > 0.05). For arthralgia, sleep disorders, malaise, movement disorders, and Guillain−Barre syndrome, the p-value was found to be more than 0.05, which indicates no significant publication bias. However, for all other manifestations, the p-value for the Egger test was found to be less than 0.05, which indicates significant publication bias (Figures S23−S42) .

The present study analyzed 240 studies with data of 190 785 patients to determine the association between the occurrence of neurological problems and COVID-19 infection. The neurological manifestations were broadly classified into nonspecific, CNS, and PNS manifestations. The nonspecific manifestations could be the systemic features of viral infection and indicators of disturbed homeostasis. Headache, fatigue, nausea, vomiting, myalgia, dizziness, and malaise were the commonly reported nonspecific manifestations. 19, 20 The current analysis results have shown headache, fatigue, myalgia, dizziness, nausea, and vomiting as highly reported neurological manifestations in COVID-19 patients.

Central nervous system involvement in COVID-19 pathophysiology is evident, as COVID-19 patients are diagnosed with several CNS manifestations. Altered mental status or disturbances in consciousness was found to be a significant manifestation in COVID-19 patients. 21, 22 Our analysis has also found altered mental status as a significant manifestation in COVID-19 patients with a pooled proportion of 17.1% (12.3−22.5) . The stupor, coma, and somnolence were the specific manifestations associated with consciousness; additionally, bradypsychia and the acute confusional syndrome were also reported. 23 In a brain imaging study, the brain images of patients with altered mental status showed white matter microangiopathic changes, chronic infracts, and incidental meningioma. 24 The involvement of CNS in SARS-Cov-2 infection is confirmed. 22 Encephalitis including limbic encephalitis radiological acute disseminated encephalomyelitis, cytotoxic lesions of the corpus callosum, and radiological acute hemorrhagic necrotizing encephalopathy was reported in COVID-19 patients. The brain imaging of these patients showed the typical feature of viral encephalitis such as leptomeningeal enhancement and elevated protein levels, but RT-PCR for SARS-CoV-2 was found negative in CSF samples. 25 Encephalopathies such as posthypoxic leukoencephalopathy, metabolic or toxic encephalopathy, septic encephalopathy, posterior reversible encephalopathy syndrome, and diffuse symmetric leukoencephalopathy were the major manifestations found in neuroimaging studies. 5,26−29 The results of our analysis have found encephalitis and encephalopathy with pooled proportions 0.6% (0.2−1.3) and 23.5% (14.3−34.1), respectively. In addition these behavioral manifestations such as agitation, confusion, anxiety, depression and psychosis were also reported in COVID-19 patients. 23, 30 The confusion was reported in 13 studies with a pooled proportion of 14.2% (6.9−23.5). Sleep disorders reported were insomnia and pathological wakefulness. 30−32 We have found sleep disorders in 5 studies with a pooled proportion of 14.9% (1.9−36.8).

Seizure or epilepsy was reported in COVID-19 patients who had and who did not have a prior history of seizure. 26 In children, both febrile seizures and nonfebrile seizures were reported. 33 Magnetic resonance imaging showed perfusion abnormalities related to seizures in COVID-19 patients with seizures. The current analysis results have found seizures in 24 studies with a pooled proportion of 4.05% (2.5−5.8). The possible factors that can account for the occurrence of seizures can be iatrogenic, metabolic alterations, and potential changes related to encephalitis. 34 Proinflammatory cytokines, blood− brain barrier (BBB) disruption, mitochondrial disturbance, and abnormal coagulation in COVID-19 patients can contribute to epilepsy. 35 Movement disorders reported in COVID-19 patients were characterized by tremors, myoclonus, and nonspecific psychomotor agitation. Additionally, balance disorders were also reported in the same studies. 36, 37 Our study has found significant involvement of movement disorders in COVID-19 patients.

Cerebrovascular diseases are the most commonly reported neurological manifestation in COVID-19 patients. Ischemic stroke, hemorrhagic stroke, cerebral vasculitis, and cerebral venous thrombosis are the majorly reported cerebrovascular diseases. 38−40 Neuroimaging studies showed subacute and acute ischemic infarct, acute hemorrhage, intracranial hemorrhage, and cranial nerves enhancement in COVID-19 patients with cerebrovascular diseases. 40,41 The ischemic stroke reported in COVID-19 patients can be classified as small vessel disease, large vessel disease, cardioembolic, and stroke of determined and undetermined origin. 42 In a retrospective casecontrol study it has been shown that COVID-19 is mainly associated with large vessel occlusion strokes rather than the small vessel occlusion strokes. 43 Current evidence suggests that the prothrombotic effect of the inflammatory response caused by cytokine storm in COVID-19 patients might account for the triggering of ischemic stroke. 40 Another study showed that COVID-19 patients with stroke have a higher in-hospital mortality rate. 39 It has also been reported that detection of acute stroke can be a strong prognostic marker of the poor patient outcome as it is the most common neuroimaging finding among the COVID-19 patients. 44 The results of the current analysis have also found significant cerebrovascular diseases in COVID-19 patients of 28 studies with a pooled proportion of 9.9% (6.8−13.4).

The results of our analysis have shown smell and taste disturbances as major PNS manifestations reported in COVID-19 patients. Hyposmia and anosmia were the main olfactory dysfunctions, and their severity ranges from mild to moderate to severe. 45, 46 In a multicentric study it has been shown that the prevalence of olfactory dysfunctions was significantly higher in the mild form compared to moderate to critical forms and about 95% of patients recovered from olfactory dysfunction in 6 months. 47 The possible mechanism for olfactory dysfunction in COVID-19 infection can be nasal obstruction, loss of olfactory receptor neurons, brain infiltration affecting olfactory centers, and damage to the olfactory epithelium. 48 ACE-2 receptors are highly expressed in the nasal cavity and olfactory bulb, and this can be the potential pathway for olfactory dysfunction as SARS-CoV-2 has a greater affinity toward the ACE-2 receptor. 49 Olfactory dysfunction can be a prognostic marker for the prediction of severity of disease as persistent olfactory dysfunction at 20 days is associated with disease severity. 50 Olfactory dysfunctions are often reported together with gustatory dysfunction. Ageusia, dysgeusia, and hypogeusia were the main gustatory dysfunctions. 45 Neuralgia and arthralgia were prominent in COVID-19 patients. 51, 52 Guillain−Barre syndrome (GBS), an autoimmune disorder, has been reported in COVID-19 patients. 53, 54 All the variants of GBS such as acute inflammatory demyelinating polyradiculoneuropathy (AIDP), critical illness myopathy and neuropathy (CRIMYNE), peripheral polyneuropathies (PNP), acute motor axonal neuropathy (AMAN), and acute motorsensory axonal neuropathy (AMSAN) have been reported in COVID-19 patients. 17, 22 Magnetic resonance imaging of COVID-19 patients with GBS showed enhancement of caudal nerve roots and enhancement of facial nerve bilaterally. 53 Demyelinating pattern in either facial or trigeminal nerve was seen in COVID-19 patients with GBS, suggesting the involvement of cranial nerve. 22 Demyelination was the main association between COVID-19 and GBS; COVID-19 GBS seems to be more severe than non-COVID-19 GBS, and care should be taken for proper diagnosis. 54 Our analysis has shown significant involvement of GBS in COVID-19 patients with a pooled proportion of 6.9% (2.3−13.7). 

A Review of Coronavirus Disease-2019 (COVID-19)

An Interactive Web-Based Dashboard to Track COVID-19 in Real Time

Clinical Characteristics of Coronavirus Disease 2019 in China

2020) Cardiovascular Disease and COVID-19

Nervous System Involvement in Coronavirus Disease 2019: Results from a Retrospective Consecutive Neuroimaging Cohort

Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis

Characteristics of Lymphocyte Subsets and Cytokines in Peripheral Blood of 123 Hospitalized Patients with

Nervous System Involvement after Infection with COVID-19 and Other Coronaviruses

Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses

Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools

Sars-Cov-2: Underestimated Damage to Nervous System

Neurologic Features in Severe SARS-CoV-2 Infection

Infectivity of Human Coronavirus in the Brain

Neurological Manifestations in COVID-19 Infection: A Systematic Review and Meta-Analysis. Can

Neurological Manifestations of COVID-19: A Systematic Review and Meta-Analysis of Proportions

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

Evolution of Altered Sense of Smell or Taste in Patients with Mildly Symptomatic COVID-19

Clinical Characteristics of 113 Deceased Patients with Coronavirus Disease 2019: Retrospective Study

Characteristics and Predictors of Death among 4035 Consecutively Hospitalized Patients with COVID-19 in Spain

Brain Imaging Utilization and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States

Neurological Predictors of Clinical Outcomes in Hospitalized Patients With COVID-19

Cerebrospinal Fluid Features in COVID-19 Patients with Neurologic Manifestations: Correlation with Brain MRI Findings in 58 Patients

Retrospective Analysis of Clinical Characteristics of 405 Patients with COVID-19

Clinical Characteristics of 116 Hospitalized Patients with COVID-19 in Wuhan, China: A Single-Centered, Retrospective, Observational Study

Multicentre Italian Study of SARS-CoV-2 Infection in Children and Adolescents, Preliminary Data as at 10

Retrospective Observational Study of Brain MRI Findings in Patients with Acute SARS-CoV-2 Infection and Neurologic Manifestations

How Does the COVID-19 Cause Seizure and Epilepsy in Patients? The Potential Mechanisms

Neurological Manifestations Associated with COVID-19: A Multicentric Registry

Neurological Consultations and Diagnoses in a Large

Guillain-BarréSyndrome Associated with SARS-CoV-2

Guillain-BarreŚ yndrome and COVID-19: An Observational Multicentre Study from Two Italian Hotspot Regions

Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients with COVID-19

Clinical Features, Laboratory Characteristics, and Outcomes of Patients Hospitalized with Coronavirus Disease 2019 (COVID-19): Early Report from the United States

Clinical, Epidemiological, and Laboratory Characteristics of Mild-to-Moderate COVID-19 Patients in Saudi Arabia: An Observational Cohort Study

Clinical Characteristics of Non-Intensive Care Unit COVID-19 Patients in Saudi Arabia: A Descriptive Cross-Sectional Study

Silent Disease and Loss of Taste and Smell Are Common Manifestations of SARS-COV-2 Infection in a Quarantine Facility: Saudi Arabia

Clinical Characteristics of COVID-19 in Saudi Arabia: A National Retrospective Study

Clinical Profile of Elderly Patients with COVID-19 Hospitalized in Indonesia's National General Hospital

Epidemiological and Clinical Course of 483 Patients with COVID-19 in Wuhan, China: A Single-Center, Retrospective Study from the Mobile Cabin Hospital

Compare the Epidemiological and Clinical Features of Imported and Local COVID-19 Cases in Hainan

A Structural Equation Model to Examine the Clinical Features of Mild-to-Moderate COVID-19: A Multicenter Italian Study

Acute-Onset Smell and Taste Disorders in the Context of COVID-19: A Pilot Multicentre Polymerase Chain Reaction Based Case-Control Study

Clinical Characteristics, Symptoms and Outcomes of 1054 Adults Presenting to Hospital with Suspected COVID-19: A Comparison of Patients with and without SARS-CoV-2 Infection

Clinical Features and Outcomes of 105 Hospitalized Patients With COVID-19 in

Characteristics of Health Care Personnel with COVID-19  United States

Olfactory and Gustatory Dysfunction as an Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study

Clinical Characteristics, Associated Factors, and Predicting COVID-19 Mortality Risk: A Retrospective Study in Wuhan, China

Anosmia and Dysgeusia Associated with SARS-CoV-2 Infection: An Age-Matched Case-control Study

Neurological Complications in a Predominantly African American Sample of COVID-19 Predict Worse Outcomes during Hospitalization

Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China

2020) Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study

Clinical Characteristics and Intrauterine Vertical Transmission Potential of COVID-19 Infection in Nine Pregnant Women: A Retrospective Review of Medical Records

Clinical Characteristics of 54 Medical Staff with COVID-19: A Retrospective Study in a Single Center in Wuhan

Clinical Course, and Outcomes of Critically Ill Adults with COVID-19 in

Characteristics and Outcomes of a Sample of Patients with COVID-19 Identified through Social Media in Wuhan, China: Observational Study

Correlation Analysis between Disease Severity and Clinical and Biochemical Characteristics of 143 Cases of COVID-19 in Wuhan, China: A Descriptive Study

Smell and Taste Disorders during COVID-19 Outbreak: Cross-Sectional Study on 355 Patients

Clinical Characteristics of Fatal and Recovered Cases of Coronavirus Disease 2019 in Wuhan, China: A Retrospective Study

Clinical Manifestations and Outcomes of Critically Ill Children and Adolescents with Coronavirus Disease

Clinical Characteristics and Respiratory Support of 310 COVID-19 Patients, Diagnosed at the Emergency Room: A Single-Center Retrospective Study

Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study

Epidemiology and Clinical Features of Coronavirus Disease 2019 in Moroccan Children

Clinical Characteristics, Predictors of Symptomatic Coronavirus Disease 2019 and Duration of Hospitalisation in a Cohort of

Early Brain Imaging Shows Increased Severity of Acute Ischemic Strokes with Large Vessel Occlusion in COVID-19 Patients

The Characteristics and Outcomes of 681 Severe Cases with COVID-19 in China

Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study

COVID-19 in Parkinson's Disease Patients Living in Lombardy

Clinical Characteristics and Short-Term Outcomes of Severe Patients With COVID-19 in Wuhan

Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions

A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in

Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris

Epidemiological and Clinical Characteristics of Patients with COVID-19 from a Designated Hospital in Hangzhou City: A Retrospective Observational Study

Multicentre Italian Study of SARS-CoV-2 Infection in Children and Adolescents

2020) Characteristics, Outcomes and Indicators of Severity for Covid-19 among Sample of Esna Quarantine Hospital's Patients, Egypt: A Retrospective Study

Self-Reported Olfactory and Taste Disorders in Patients with Severe Acute Respiratory Coronavirus 2 Infection: A Cross-Sectional Study

Evolution of Olfactory Disorders in COVID-19 Patients

Clinical Characteristics of 194 Cases of COVID-19 in Huanggang and Taian

Clinical and Hematological Characteristics of 88 Patients with COVID-19

Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia

Psychophysical Tests Reveal Impaired Olfaction but Preserved Gustation

Clinical Features and Outcomes of 98 Patients Hospitalized with Sars-Cov-2 Infection in Daegu, South Korea: A Brief Descriptive Study

Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan

Epidemiological Features of 105 Patients Infected with the COVID-19

Distinct Clinical Characteristics and Risk Factors for Mortality in Female Inpatients With Coronavirus Disease 2019 (COVID-19): A Sex-Stratified

Changes in the Clinical Characteristics of 62 Patients Who Died from Coronavirus Disease

Clinical Characteristics of Emergency Surgery Patients Infected with Coronavirus Disease 2019 (COVID-19) Pneumonia in Wuhan

Comparison of Epidemiological and Clinical Characteristics of COVID-19 Patients with and without Wuhan Exposure

Zhejiang Province in China

Clinical Outcomes of COVID-19 in Wuhan, China: A Large Cohort Study

ah (2020) Epidemiological and Clinical Characteristics of Coronavirus Disease

Frequency and Outcome of Olfactory Impairment and Sinonasal Involvement in Hospitalized Patients with COVID-19

Clinical Characteristics and Online Mental Health Care of Asymptomatic or Mildly Symptomatic Patients with Coronavirus Disease

Characteristics of Disease Progress in Patients with Coronavirus Disease

Clinical Characteristics of Re-Positive COVID-19 Patients in Huangshi, China: A Retrospective Cohort Study

Epidemiological and Clinical Features of 201 COVID-19 Patients in Changsha City

Clinical Characteristics and Outcome of Hospitalized Patients with SARS-CoV-2 Infection at Toulouse University Hospital (France). Results from the Covid-Clinic-Toul Cohort

Clinical Characteristics of Novel Coronavirus Cases in Tertiary Hospitals in Hubei Province

COVID-19: Comparative Clinical Features and Outcome in 114 Patients with or without Pneumonia

A Prospective Clinical Study of Detailed Neurological Manifestations in Patients with COVID-19

Epidemiological and Clinical Characteristics of Coronavirus Disease (COVID-19) Cases at a Screening Clinic during the Early Outbreak Period: A Single-Centre Study

Characteristics Associated with Hospitalization Among Patients with COVID-19

Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19

Characteristics and Outcomes of Admitted Patients Infected with SARS-CoV-2 in Uganda

Features of Anosmia in COVID-19

Prevalence and Clinical Presentation of Health Care Workers With Symptoms of Coronavirus Disease 2019 in 2 Dutch Hospitals During an Early Phase of the Pandemic

Neurology of COVID-19 in Singapore

Clinical Characteristics of the First Known Cases of Death Caused by COVID-19 Pneumonia

The Epidemiological and Clinical Characteristics of 81 Children with COVID-19 in a Pandemic Hospital in Turkey: An Observational Cohort Study

Incomplete and Late Recovery of Sudden Olfactory Dysfunction in COVID-19

Clinical and Radiographic Characteristics, Management and Short-Term Outcomes of Patients with COVID-19 in Wenzhou

Coronavirus Disease 2019 in Elderly Patients: Characteristics and Prognostic Factors Based on 4-Week Follow-Up

Epidemiological and Clinical Features of 200 Hospitalized Patients with Corona Virus Disease 2019 Outside Wuhan, China: A Descriptive Study

Anosmia and Ageusia as Predictive Signs of COVID-19 in Healthcare Workers in Italy: A Prospective Case-Control Study

COVID-19 Symptoms Predictive of Healthcare Workers' SARS-CoV-2 PCR Results

Clinical Features of 1487 COVID-19 Patients with Outpatient Management in the Greater Paris: The COVID-Call Study

Psychophysical Evaluation of Chemosensory Functions 5 Weeks after Olfactory Loss Due to COVID-19: A Prospective Cohort Study on 72 Patients

Olfactory and Gustatory Dysfunctions as a Clinical Presentation of Mild-to-Moderate Forms of the Coronavirus Disease (COVID-19): A Multicenter European Study

Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients

Clinical Characteristics and Outcomes of Critically Ill Patients with COVID-19 in a Tertiary Community Hospital in Upstate New York

Cerebrospinal Fluid Features in COVID-19 Patients with Neurologic Manifestations: Correlation with Brain MRI Findings in 58 Patients

Time Course of Anosmia and Dysgeusia in Patients with Mild SARS-CoV-2 Infection

The Associated Factors of Anxiety and Depressive Symptoms in COVID-19 Patients Hospitalized in Wuhan

Clinical Features and Short-Term Outcomes of Elderly Patients with COVID-19

Discharged Cases with Coronavirus Disease

2020) Frequent Neurologic Manifestations and Encephalopathy-Associated Morbidity in Covid-19 Patients

Association between Initial Chest CT or Clinical Features and Clinical Course in Patients with Coronavirus Disease 2019 Pneumonia

Venous and Arterial Thromboembolic Complications in COVID-19 Patients Admitted to an Academic Hospital in

Assessment of Neurological Manifestations in Hospitalized Patients with COVID

Prevalence and Recovery Time of Olfactory and Gustatory Dysfunction in Hospitalized Patients with COVID-19 in Wuhan

Clinical Findings of Patients with Coronavirus Disease

Clinical Characteristics and Predictors of Disease Progression in Severe Patients with COVID-19 Infection in Jiangsu Province, China: A Descriptive Study

Analysis of Clinical Features and Outcomes of 161 Patients with Severe and Critical COVID-19: A Multicenter Descriptive Study

Epidemiological and Clinical Characteristics of SARS-CoV-2 Infection among Healthcare Workers in Hubei Province of China

Characteristic of 523 COVID-19 in Henan Province and a Death Prediction Model

Epidemiological and Clinical Characteristics of SARS-CoV-2 Infections at a Testing Site

Epidemiological and Clinical Characteristics of the First 557 Successive Patients with COVID-19 in Pernambuco State, Northeast Brazil

Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease

Clinical Presentation and Outcome across Age Categories among Patients with COVID-19 Admitted to a Spanish Emergency Department

2020) Functional and Cognitive Outcomes after COVID-19 Delirium

Headache as a Cardinal Symptom of Coronavirus Disease 2019: A Cross-Sectional Study

Sex-Specific Clinical Characteristics and Prognosis of Coronavirus Disease-19 Infection in Wuhan, China: A Retrospective Study of 168 Severe Patients

Clinical Characteristics of Refractory COVID-19 Pneumonia in Wuhan

Loss of Taste and Smell Are Common Clinical Characteristics of Patients with COVID-19 in Somalia: A Retrospective Double Centre Study

Clinical Characteristics and Mortality Predictors of COVID-19 Patients Hospitalized at Nationally-Designated Treatment Hospitals

Clinical Outcomes in Critically Ill Coronavirus Disease 2019 Patients: A Unique New York City Public Hospital Experience

The First 100 Cases of Covid-19 in a Hospital in Madrid with a 2-Month Follow-Up

Neurological Implications of Non-Critically Ill Patients With ACS Chemical Neuroscience pubs

Coronavirus Disease 2019 in a Fangcang Shelter Hospital in Wuhan

Acute Onset Olfactory/Taste Disorders Are Associated with a High Viral Burden in Mild or Asymptomatic SARS-CoV-2 Infections

Clinical Characteristics and Outcomes among Brazilian Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: An Observational Retrospective Study

Clinical Characteristics and Short-Term Outcomes of Patients with Coronavirus Disease 2019: A Retrospective Single-Center Experience of a Designated Hospital in Poland

Clinical Characteristics of Imported and Second-Generation Coronavirus Disease 2019 (COVID-19) Cases in Shaanxi Outside Wuhan, China: A Multicentre Retrospective Study

Smell and Taste Alterations in COVID-19: A Cross-Sectional Analysis of Different Cohorts

Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects. Otolaryngol

The Emerging Spectrum of COVID-19 Neurology: Clinical, Radiological and Laboratory Findings

Clinical Features of Critically Ill Patients Infected with SARS-CoV-2 Outside Wuhan with and without Diabetes

Remote Psychophysical Evaluation of Olfactory and Gustatory Functions in Early-Stage Coronavirus Disease 2019 Patients: The Bologna Experience of 300 Cases

High Prevalence of Headaches During Covid-19 Infection: A Retrospective Cohort Study

Clinical Characteristics of Hospitalized Patients with COVID-19 in Sofia, Bulgaria. Vector-Borne Zoonotic Dis

Clinical Characteristics of 145 Patients with Corona Virus Disease

Epidemiology and Clinical Characteristics of 43 COVID-19 Patients in Weifang

Clinical Characteristics and Outcomes of COVID-19 Patients with a History of Stroke in Wuhan

Clinical and Epidemiological Features of 36 Children with Coronavirus Disease 2019 (COVID-19) in Zhejiang, China: An Observational Cohort Study

Clinical and Epidemiological Features Discriminating Confirmed COVID-19 Patients from SARS-CoV-2 Negative Patients at Screening Centres in Madagascar

Contemporary Analysis of Olfactory Dysfunction in Mild to Moderate Covid 19 Patients in A Tertiary Health Care Centre

Neurologic Manifestations in 1760 COVID-19 Patients Admitted to Papa Giovanni XXIII Hospital

Chemosensory Dysfunction in COVID-19 out-Patients

Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19

Self-Reported Loss of Smell without Nasal Obstruction to Identify COVID-19. The Multicenter Coranosmia Cohort Study

Epidemiological and Clinical Characteristics of COVID-19 in Indian Children in the Initial Phase of the Pandemic

Coronavirus 2019 (COVID-19)-Associated Encephalopathies and Cerebrovascular Disease: The New Orleans Experience

Clinical Features, Diagnostics, and Outcomes of Patients Presenting with Acute Respiratory Illness: A Retrospective Cohort Study of Patients with and without COVID-19. EClinicalMedicine 27

Clinical Characteristics and Changes of Chest CT Features in 307 Patients with Common COVID-19 Pneumonia Infected SARS-CoV-2: A Multicenter Study in Jiangsu

Neurological Complications Among Native Americans with COVID-19: Our Experience at a Tertiary Care Academic Hospital in the U

Radiological Findings from 81 Patients with COVID-19 Pneumonia in Wuhan, China: A Descriptive Study

A Comparison of Clinical Characteristics and Outcomes in Elderly and Younger Patients with Covid-19

Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics. Otolaryngol.-Head Neck Surg

Ct Quantitative Analysis and Its Relationship with Clinical Features for Assessing the Severity of Patients with COVID-19

Clinical Course and Outcomes of 3,060 Patients with Coronavirus Disease 2019 in Korea

Clinical Characteristics of Children and Young People Admitted to Hospital with Covid-19 in United Kingdom: Prospective Multicentre Observational Cohort Study

Clinical Characteristics of 132 Healthcare Worker Cases with COVID-19: A Retrospective Study from a Single Center in Wuhan

Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study

Clinical Characteristics of COVID-19 in 104 People with SARS-CoV-2 Infection on the Diamond Princess Cruise Ship: A Retrospective Analysis

Characteristics of Adult Outpatients and Inpatients with COVID-19-11 Academic Medical Centers, United States

Olfactory Taste Disorder as a Presenting Symptom of COVID-19: A Large Single-Center Singapore Study

New Loss of Smell and Taste: Uncommon Symptoms

Clinical Features of 95 Sequential Hospitalised Patients with Novel Coronavirus 2019 Disease (COVID-19), the First UK Cohort

Strong Associations and Moderate Predictive Value of Early Symptoms for SARS-CoV-2 Test Positivity among Healthcare Workers, the Netherlands

Factors Associated with the Presence of Headache in Hospitalized COVID-19 Patients and Impact on Prognosis: A Retrospective Cohort Study

Early Neurological Manifestations of Hospitalized COVID-19 Patients

Validation of a Self-Administered Olfactory and Gustatory Test for the Remotely Evaluation of COVID-19 Patients in Home Quarantine

Bin (2020) Clinical Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov2) Patients in Hospital Tengku Ampuan Afzan

XXX, XXX−XXX ment and in-Hospital Mortality of Patients with Coronavirus Disease

Olfactory and Taste Disorders in Healthcare Workers with COVID-19 Infection

Clinical and CT Features of the COVID-19 Infection: Comparison among Four Different Age Groups

Clinical Features and Potential Risk Factors for Discerning the Critical Cases and Predicting the Outcome of Patients with COVID-19

Clinical Characteristics and Imaging Manifestations of the 2019 Novel Coronavirus Disease (COVID-19):A Multi-Center Study in Wenzhou City

Clinical Characteristics and Outcomes in Elderly with Coronavirus Disease

Clinical Characteristics of 28 Patients with Diabetes and Covid-19 in Wuhan

Clinical Characteristics of 199 Discharged Patients with COVID-19 in Fujian Province: A Multicenter Retrospective Study between

Critically ILL Patients with Coronavirus Disease 2019 in a Designated ICU: Clinical Features and Predictors for Mortality

Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study

Epidemiological and Clinical Characteristics of Fifty-Six Cases of COVID-19 in Liaoning Province

Clinical Characteristics and Outcomes of 421 Patients With Coronavirus Disease

Clinical Characteristics and Manifestations in Older Patients with COVID-19

Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease

Analysis of Clinical Features and Early Warning Signs in Patients with Severe COVID-19: A Retrospective Cohort Study

Clinical Characteristics of Non-Critically Ill Patients with Novel Coronavirus Infection (COVID-19) in a Fangcang Hospital

Imaging and Clinical Features of Patients with 2019 Novel Coronavirus SARS-CoV-2

Clinical Characteristics of Patients with 2019 Coronavirus Disease in a Non-Wuhan Area of Hubei Province, China: A Retrospective Study

Clinical Characteristics and Prognosis of 218 Patients With COVID-19: A Retrospective Study Based on Clinical Classification

Clinical Characteristics and Outcomes of Critically Ill Patients with Novel Coronavirus Infectious Disease (COVID-19) in China: A Retrospective Multicenter Study

New Onset Neurologic Events in People with COVID-19 in 3 Regions in China

Clinical and Computed Tomographic Imaging Features of Novel Coronavirus Pneumonia Caused by SARS-CoV-2

Clinical Characteristics and Treatment of Critically Ill Patients with COVID-19 in Hebei

Acute Cerebrovascular Disease Following COVID-19: A Single Center

Baseline Characteristics and Risk Factors for Short-Term Outcomes in 132 COVID-19 Patients with Diabetes in Wuhan China: A Retrospective Study

Clinical and Biochemical Indexes from 2019-NCoV Infected Patients Linked to Viral Loads and Lung Injury

2020) A Comparative-Descriptive Analysis of Clinical Characteristics in 2019-Coronavirus-Infected Children and Adults

Clinical and Radiological Characteristics of COVID-19: A Multicentre, Retrospective, Observational Study

Clinical Characteristics of 276 Hospitalized Patients with Coronavirus Disease

Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19

Epidemiological and Clinical Characteristics Analysis of COVID-19 in the Surrounding Areas of Wuhan

Association of Chemosensory Dysfunction and COVID-19 in Patients Presenting with Influenza-like Symptoms

Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study

A Retrospective Study of Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Hospitalized Adult Patients

Clinical and Neuroimaging Correlation in Patients with COVID-19

Clinical Characteristics of the Coronavirus Disease 2019 (COVID-19) Outbreak on a Cruise Ship

Clinical Characteristics on Admission Predict In-Hospital Fatal Outcome in Patients Aged ≥75 Years with Novel Coronavirus Disease (COVID-19): A Retrospective Cohort Study

Clinical Characteristics of Coronavirus Disease

Childhood COVID-19: A Multicentre Retrospective Study

Clinical Features of 69 Cases with Coronavirus Disease

Older Patients With SARS-Cov-2 Infection Admitted to Acute Care Geriatric Wards

Clinical Features and Short-Term Outcomes of 221 Patients with COVID-19 in Wuhan

Relation between Chest CT Findings and Clinical Conditions of Coronavirus Disease (Covid-19) Pneumonia: A Multicenter Study

Clinical Characteristics of Acute Respiratory Syndrome with SARS-CoV-2 Infection in Children in South China

Epidemiological and Clinical Characteristics of COVID-19 Patients in Hengyang

Clinical Features Predicting Mortality Risk in Older Patients with COVID-19